American Journal of Transplantation· 2014Q1
Long-Term Results in Recipients of Combined HLA-Mismatched Kidney and Bone Marrow Transplantation Without Maintenance Immunosuppression
- 279citations
- Q1SCImago
- 2014year
Short summary
Four out of 10 patients achieved long-term (4.5-11.4 years) kidney transplant survival without immunosuppression after a combined kidney and bone marrow transplant, with four doses of rituximab preventing donor-specific antibody formation.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Transplantation
TransplantationMedicine